Physician

Ann E Warner, M.D.

According to 2025 Medicare claims, Ann Warner, M.D. (NPI: 1750343455) practices rheumatology in the Kansas City, MO-KS market, with the plurality of this provider's patient population coming from Jackson, MO. This provider's primary affiliated billing organization is KANSAS CITY PHYSICIAN PARTNERS INC (NPI: 1831531466; TIN: 463233706) and primary practice location at 64111-3315. Warner is affiliated with the Aledade 98 MO MSSP Enhanced (ACO ID: A4998) and Centrus Health of Kansas LLC (ACO ID: A5305), participating under the MSSP model.

Warner's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 729 traditional Medicare patients, billed 187,313 HCPCS/CPT codes, and received $1,332,898 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 5,169 prescription claims across 828 beneficiaries totaling $2,611,416 in drug costs, led by Xeljanz Xr (Tofacitinib Citrate). 2021 DME data shows 41 claims. Open Payments data shows 1 records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $876,057 to $2,611,416. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	875	95,815	$1,323,981
2016	868	86,314	$1,255,195
2017	940	78,258	$1,037,442
2018	886	67,214	$1,175,656
2019	831	48,609	$848,370
2020	770	67,811	$955,003
2021	819	92,916	$1,104,381
2022	833	133,245	$1,145,817
2023	743	142,783	$1,134,889
2024	729	187,313	$1,332,898

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	646	4,551	$876,057
2016	654	4,772	$1,047,589
2017	682	4,864	$862,547
2018	693	5,037	$1,143,654
2019	722	5,394	$1,244,550
2020	733	5,487	$1,475,237
2021	738	5,098	$1,782,452
2022	782	5,072	$2,404,521
2023	798	5,049	$2,453,064
2024	828	5,169	$2,611,416

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	28	$57,964
2017	N/R	26	$49,951
2018	N/R	13	$25,142
2019	N/R	27	$25,058
2020	N/R	23	$37,354
2021	N/R	41	$56,535
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	561	891	$85
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	380	464	$12
36415	Insertion of needle into vein for collection of blood sample	528	1,138	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	505	1,045	$8
86140	Measurement c-reactive protein for detection of infection or inflammation	439	759	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xeljanz Xr	Tofacitinib Citrate	90	2,940	$577,655
Humira(Cf) Pen	Adalimumab	66	2,016	$494,435
Enbrel Sureclick	Etanercept	56	1,568	$418,366
Humira(Cf)	Adalimumab	42	1,204	$322,345
Orencia	Abatacept	26	728	$144,242

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	0	$0	N/R
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	1	$1,304	Consortium of Independent Immunology Clinics, LLC

Explore More Providers

FAQ

What Medicare data is available for Ann E. Warner, M.D.?

Tedicare shows public-source Medicare data for Ann E. Warner, M.D. (NPI 1750343455), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ann E. Warner, M.D. have ACO affiliation data?

Ann E. Warner, M.D. is shown with ACO affiliation data for Aledade 98 MO MSSP Enhanced (MSSP, ACO ID A4998) and Centrus Health of Kansas LLC (MSSP, ACO ID A5305).

What billing organization is linked to Ann E. Warner, M.D.?

Ann E. Warner, M.D. is linked to KANSAS CITY PHYSICIAN PARTNERS INC (billing NPI 1831531466) in the available physician profile data.

Does Ann E. Warner, M.D. have Open Payments data?

Ann E. Warner, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.